AU2002320072A1 - Use of anti-tnf antibodies as drugs in treating septic disorders of anemic patients - Google Patents

Use of anti-tnf antibodies as drugs in treating septic disorders of anemic patients

Info

Publication number
AU2002320072A1
AU2002320072A1 AU2002320072A AU2002320072A AU2002320072A1 AU 2002320072 A1 AU2002320072 A1 AU 2002320072A1 AU 2002320072 A AU2002320072 A AU 2002320072A AU 2002320072 A AU2002320072 A AU 2002320072A AU 2002320072 A1 AU2002320072 A1 AU 2002320072A1
Authority
AU
Australia
Prior art keywords
drugs
tnf antibodies
treating septic
anemic patients
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002320072A
Inventor
William T. Barchuk
Steven A. Fischkoff
Leah S. Teoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of AU2002320072A1 publication Critical patent/AU2002320072A1/en
Abandoned legal-status Critical Current

Links

AU2002320072A 2001-05-25 2002-05-23 Use of anti-tnf antibodies as drugs in treating septic disorders of anemic patients Abandoned AU2002320072A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/293,818 2001-05-25

Publications (1)

Publication Number Publication Date
AU2002320072A1 true AU2002320072A1 (en) 2002-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
IL212419A0 (en) Methods of administering anti-tnf antibodies
WO2003033720A8 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
EP1482972A4 (en) Treatment of immunological disorders using anti-cd30 antibodies
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
PL398596A1 (en) Preparation containing human antibodies for the treatment of disorders associated with TNF-α
IL157161A0 (en) Methods for treating disease states comprising administration of low levels of antibodies
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
AU2003225160A1 (en) "biosensor for dialysis therapy"
HUP0301235A3 (en) Treatment of central nervous system diseases by antibodies against glatiramer acetate
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2001288342A1 (en) Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
AU2001266604A1 (en) Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
MXPA03008634A (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases.
AU2002368331A1 (en) Passive hyperimmune antibody therapy in the treatment of anthrax
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2002322263A1 (en) Eglin c based drugs for treatment of disease
AU2002238673A1 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
AU2002320072A1 (en) Use of anti-tnf antibodies as drugs in treating septic disorders of anemic patients
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
AUPR520701A0 (en) Herbal composition for the treatment of drug addiction
AU2002242293A1 (en) Treatment of neurological disease
AUPR618501A0 (en) Composition for treatment of patients with kidney stones, gout and arthritis
AU2002365654A1 (en) Treatment of diseases via the skin